The arrival of the Retatru vial represents a significant breakthrough in the approach to weight regulation. This groundbreaking drug combines dual mechanisms – agonist of the GLP-1 receptor and inhibition of the DPP-4 enzyme – suggesting a distinctive method for managing excess weight . Early cli